The increase in price target by Citigroup suggests a positive outlook on Xylem's stock value in the short term, potentially leading to an upward movement in its stock price. However, the Neutral rating indicates that the analyst sees the stock as fairly valued at its current price, balancing the potential for both growth and risk.